Efficacy of 3-day low dose quinine plus clindamycin versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children (CLINDAQUINE): an open-label randomized trial.

Obonyo, Charles O; Juma, Elizabeth A; Were, Vincent O; Ogutu, Bernhards R

Obonyo, Charles O; Juma, Elizabeth A; Were, Vincent O; Ogutu, Bernhards R.

Affiliation

Obonyo CO; Centre for Global Health Research, Kenya Medical Research Institute, P.O. Box 1578, Kisumu, Kenya. cobonyo65@yahoo.com.
Juma EA; Centre for Clinical Research, Kenya Medical Research Institute, P.O. Box 20778, Nairobi, Kenya.
Were VO; Centre for Global Health Research, Kenya Medical Research Institute, P.O. Box 1578, Kisumu, Kenya.
Ogutu BR; Centre for Clinical Research, Kenya Medical Research Institute, P.O. Box 20778, Nairobi, Kenya.

Malar J ; 21(1): 30, 2022 Feb 02.

Article in En | MEDLINE | ID: mdl-35109841

Subject(s)

Artemether, Lumefantrine Drug Combination/therapeutic use; Clindamycin/therapeutic use; Malaria, Falciparum/drug therapy; Quinine/therapeutic use; Artemether, Lumefantrine Drug Combination/adverse effects; Child, Preschool; Clindamycin/adverse effects; Drug Therapy, Combination; Female; Humans; Infant; Kenya; Male; Quinine/adverse effects

Key words

Artemether-lumefantrine; Children; Clindamycin; Kenya; Malaria; Quinine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinine / Clindamycin / Malaria, Falciparum / Artemether, Lumefantrine Drug Combination Type of study: Clinical_trials / Guideline Limits: Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Africa Language: En Journal: Malar J Journal subject: MEDICINA TROPICAL Year: 2022 Document type: Article Affiliation country: Kenya

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google